I0038
IHC-Breast Cancer (ER, PR, HER-2/neu)
Number of Tests | 3 |
Test Included | ER, PR, HER-2/neu |
Test Details: Immunohistochemical testing helps to identify specific antigens (proteins) within tissue sections utilizing an antigen-specific antibody. Estrogen receptor (ER) and Progesterone receptor (PR) expression is seen in tumours of female sex steroid hormone responsive tissues such as the breast, endometrium, and ovary. It predicts response to hormonal therapy and is a prognostic marker for survival in breast cancer patients.
Over-expression of HER-2/neu is associated with poor prognosis of breast, ovarian, bladder, pancreatic, stomach, and oesophageal malignancies. It predicts a positive response to a monoclonal antibody, Herceptin/Trastuzumab, targeted against the HER-2/neu receptor.
![](assets/img/diagnleftimg.png)
Category
Advanced Routine Diagnostics
Pre-test Information
Demographic data, site of the specimen, clinical details & relevant investigations including radiology are mandatory.
Report Delivery
4 days after releasing H&E report
Gender
Female
Organ
Breast
IHC-Breast Cancer (ER, PR, HER-2/neu)
2970
Most Searched Diagnostic Tests